Sangamo Therapeutics
SGMO
#10606
Rank
ยฃ22.96 M
Marketcap
ยฃ0.05543
Share price
0.00%
Change (1 day)
-85.68%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2023 (TTM): -ยฃ1.16

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ0.28. In 2022 the company made an earnings per share (EPS) of -ยฃ0.94 a decrease over its 2021 EPS that were of -ยฃ0.93.

EPS history for Sangamo Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ1.1624.12%
2022-ยฃ0.940.81%
2021-ยฃ0.9333.33%
2020-ยฃ0.706.9%
2019-ยฃ0.6522.54%
2018-ยฃ0.531.43%
2017-ยฃ0.52-31.37%
2016-ยฃ0.7675.86%
2015-ยฃ0.4348.72%
2014-ยฃ0.29-17.02%
2013-ยฃ0.359.3%
2012-ยฃ0.32-39.44%
2011-ยฃ0.5329.09%
2010-ยฃ0.4122.22%
2009-ยฃ0.34-25%
2008-ยฃ0.453.45%
2007-ยฃ0.435.45%
2006-ยฃ0.4110%
2005-ยฃ0.37-9.09%
2004-ยฃ0.4130.95%
2003-ยฃ0.31-65.29%
2002-ยฃ0.9115.24%
2001-ยฃ0.793.96%
2000-ยฃ0.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.00-1,857.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ13.02-4,673.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.77-721.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ0.95 234.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ2.32 715.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ0.74-361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ14.84-5,313.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-ยฃ0.06742-76.32%๐Ÿ‡บ๐Ÿ‡ธ USA